跳至主要内容
临床试验/NCT06045780
NCT06045780招募中不适用

Study on the Mechanism of Endotoxic Acute Lung Injury-induced Golgi Stress Based on Regulating HO-1/CREB3

Tianjin Nankai Hospital1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2023年9月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
1
主要终点
cAMP-response element binding protein 3, CREB3

研究概览

简要总结

This study was an ambispective observational cohort study that included sepsis patients hospitalized in the Intensive care unit (ICU) of the Nankai Hospital. All patients met the consensus criteria of sepsis-3. The purpose of this study is to investigate the valuable biomarkers for the severity of sepsis and predictors of 30-day mortality for patients with sepsis.

详细描述

All patients met the consensus criteria of sepsis-3. The purpose of this study is to investigate the valuable biomarkers for the severity of sepsis and predictors of 30-day mortality for patients with sepsis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males or females over the age of 18;
  • Sepsis was diagnosed within 48h which meets SPESIS 3 criteria;
  • Capable of understanding the purpose and risk of the study;
  • Patients or proxy must give written informed consent before any assessment is performed.

排除标准

  • Pregnancy, lactation or perinatal period;
  • Breast carcinoma;
  • HIV seropositive or Syphilis seropositive;
  • Any clinical-relevant condition that might affect study participation and/or study results;
  • Participation in any other intervention trial;
  • Unwillingness or inability to following the study protocol in the investigators opinion.

结局指标

主要结局

cAMP-response element binding protein 3, CREB3

时间窗: Up to Day 28

CREB3 levels were measured in the PBMCs of sepsis patients and healthy controls

ADP-ribosylation factor 4, ARF4

时间窗: Up to Day 28

ARF4 levels were measured in the PBMCs of sepsis patients and healthy controls

次要结局

  • Heme oxygnase-1, HO-1(Up to Day 28)
  • Oxygenation index(Up to Day 28)
  • Mechanical ventilation days(Up to Day 28)
  • Sequential Organ-Failure Assessment (SOFA) score(Up to Day 28)
  • ARF family(Up to Day 28)
  • Inflammation biomarkers Inflammation levels(Up to Day 28)
  • ICU stay length(Up to Day 90)
  • 28 days survive(Up to Day 28)
  • Acute Physiology and Chronic Health Evaluation II (APACHE II) score(Up to Day 28)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jianbo Yu

Prof.

Tianjin Nankai Hospital

研究点 (1)

Loading locations...

相似试验